Winthrop Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Winthrop Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,590	Closed	-$303K	–	125
2022 Q1	$303K	Buy	6,590 +2,922	+80%	+$139K	0.06%	100
2021 Q4	$225K	Buy	3,668 +2	+0.1%	+$138	0.05%	128
2021 Q3	$274K	Sell	3,666 -17	-0.5%	-$1.43K	0.06%	107
2021 Q2	$340K	Sell	3,683 -33	-0.9%	-$2.81K	0.08%	90
2021 Q1	$330K	Buy	3,716 +253	+7%	+$25.1K	0.08%	89
2020 Q4	$323K	Buy	+3,463	New	+$276K	0.08%	88

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Winthrop Advisory Group's ARKG Position: Q2 2022 in Review

Winthrop Advisory Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 6,590 shares — an estimated $303K sold.

Winthrop Advisory Group first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $340K in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Winthrop Advisory Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Winthrop Advisory Group sold 6,590 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $303K.
Winthrop Advisory Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
Winthrop Advisory Group's ARK Genomic Revolution ETF position peaked at $340K in Q2 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Winthrop Advisory Group's 13F filing for Q2 2022, filed 21 Jul 2022.